Previous work by us and others has implicated a role for Ral guanine exchange factors (RalGEFs) in Ras-induced cell growth and oncogenic transformation. Here we show for the ®rst time that RalGEFs are involved in Rasinduced dierentiation as well. Expression of oncogenic Ras in F9 embryonal carcinoma (EC) cells is known to induce dierentiation to a primitive endoderm (PrE)-like phenotype, but the downstream signal transduction mechanisms involved are unclear. We found that PrE dierentiation is induced by the Ras eector domain mutants, RasV12G37 and RasV12E38, but not by RasV12C40. Accordingly, expression of constitutively active forms of RalGEF (Rlf-CAAX) or Raf1 (Raf-CAAX) is sucient to induce dierentiation. Inhibition of RalGEF activity by expression of dominant negative Ral completely abolishes Rlf-CAAX-and RasV12G37-induced dierentiation, while it reduces dierentiation by RasV12 and Raf-CAAX. Finally, while Rlf-CAAX does not increase Erk activity, inhibition of MEK blocks both Ras-as well as Rlf-CAAX-induced dierentiation, suggesting that RalGEFs induce PrE dierentiation in a manner depending on basal MEK or Erk activity. Based on these results we conclude that Ras induces PrE dierentiation of F9 EC cells via an interplay of Erkand RalGEF-mediated pathways.
Introduction
The recent ®nding that certain eector domain mutants of oncogenic Ras discriminate between various downstream pathways has given insight into the contribution of each pathway to Ras-mediated eects, such as gene expression and transformation . Of the three recognized eectors of Ras, Raf1 binds speci®cally to RasV12E38, RalGEFs to RasV12G37 and PI3-kinase to RasV12C40 (White et al., 1995; Rodriguez-Viciana et al., 1997) . Expression of these mutants separately induces no or little transformation, while they strongly synergize in transformation upon coexpression (White et al., 1995; Rodriguez-Viciana et al., 1997) . Thus, the dierent Ras eector pathways may each induce a speci®c subset of biological responses that build up the complex transformed phenotype.
We recently found that Ras functions as a regulator of extraembryonic endoderm dierentiation in vitro (Verheijen et al., 1999) . The formation of extraembryonic endoderm is the earliest developmental process in the mammalian embryo and takes place in the blastocyst around day 4.5 p.c., when cells of the inner cell mass dierentiate into primitive endoderm (PrE) . Despite the importance of extraembryonic endoderm in establishing a proper environment for embryonic development, little is known about the signals involved in the differentiation of extraembryonic endoderm. F9 embryonal carcinoma (EC) cells are a suitable in vitro model system to study the formation of extraembryonic endoderm (Strickland and Madavi, 1978) . We recently found that expression of oncogenic Ras triggers dierentiation of F9 EC cells to PrE, while Ras activity inhibits subsequent dierentiation towards parietal endoderm (Yamaguchi-Iwai et al., 1990; Verheijen et al., 1999) . Here, we analysed the signalling pathways involved in Ras-mediated PrE dierentiation in further detail. We show that Ras induces PrE dierentiation via an interdependent action of RalGEFs and Erk.
Results and discussion
To identify the eector(s) of Ras involved in PrE dierentiation, we transiently transfected F9 EC cells with b-galactosidase (b-gal) together with eector domain mutants of RasV12. By determining the morphology and the expression of dierentiation markers, such as Troma-1 (Kemler et al., 1981) and SSEA-1 (Solter and Knowles, 1978) of b-gal expressing cells, the dierentiation state of the transfected cells was investigated, as described before (Verheijen et al., 1999) . When F9 EC cells were transfected with control plasmids, they remained undierentiated, as re¯ected in their morphology, the absence of the dierentiation marker Troma-1 (Figure 1) , and the presence of the stem cell marker SSEA-1 (not shown). However, when cells were transfected with oncogenic RasV12, approximately 80% of the transfected cells had dierentiated to a PrE-like phenotype, based on the enlarged and attened morphology, the expression of Troma-1 (Figure 1 ) and the disappearance of SSEA-1 (not shown). Transfection of F9 EC cells with RasV12G37 or RasV12E38 strongly induces PrE dierentiation, in contrast to transfection with RasV12C40 ( Figure 1b) . The ability of RasV12G37 and RasV12E38 to separately mimic RasV12-induced dierentiation of F9 EC cells is in marked contrast to their eect on oncogenic transformation in which the single eector domain mutants do not mimic the eect of RasV12 (reviewed in .
Since RasV12C40 selectively binds and activates the Ras eector PI-3 kinase (Rodriguez-Viciana et al., 1997), its inability to induce dierentiation indicates that PI3-kinase and downstream targets like PKB and Rac are not directly responsible for dierentiation induced by Ras. The dierentiating potential of RasV12G37, which binds RalGEFs (Rodriguez-Viciana et al., 1997), suggests a role for Ral and RalGEFs in Ras-mediated PrE dierentiation. Accordingly, transfection of F9 EC cells with Rlf-CAAX, a constitutively active RalGEF (Wolthuis et al., 1997) , induced PrE dierentiation in contrast to transfection of the catalytically inactive form Rlf-DCAT-CAAX ( Figure 2a ). Importantly, a constitutive GTP-bound, and therefore putative active form of Ral, RalV23 (Wolthuis et al., 1997) , did not induce dierentiation. This is in agreement with our recent observations that RalV23 could not mimic Rlf-CAAX in activation of the c-fos promoter (Wolthuis et al., 1997) , and suggests either that Ral is not involved in Rlf-induced PrE dierentiation or that RalV23 does not mimic endogenously activated Ral as previously discussed ). RasV12E38, a mutant which couples to Raf1 (Rodriguez-Viciana et al., 1997), also induces dierentiation of F9 cells, suggesting that Raf1 is involved in dierentiation by Ras as well. This is in agreement with our previous ®ndings that constitutively active Raf1 or MEK is sucient to trigger PrE dierentiation (Verheijen et al., 1999) . Rlf-CAAX and a suboptimal amount of Raf-CAAX cooperate in the induction of PrE dierentiation ( Figure 2b ). Thus, Ras induces dierentiation via both Raf1 as well as RalGEF mediated pathways.
To determine the importance of the RalGEF/Ral pathway for dierentiation by Ras and Raf1, we ®rst transfected F9 cells with a dominant negative form of Ral, RalN28, thereby blocking the action of RalGEFs (Miller et al., 1997; Wolthuis et al., 1997) . Accordingly, RalN28 completely abolished Rlf-CAAX-induced PrE dierentiation (Figure 2c ), while it did not inhibit dierentiation induced by retinoic acid, an in vitro inducer of PrE dierentiation (Strickland and Madavi, 1978) . Importantly, RalN28 completely abolished dierentiation by RasV12G37, indicating that differentiation by RasV12G37 is indeed mediated by RalGEFs. PrE dierentiation by RasV12, RasV12E38 or Raf-CAAX was partly inhibited by RalN28, suggesting that RalGEF contributes to Ras-and Raf1-induced PrE dierentiation, but is not strictly required.
Previous work has shown that the Raf1/Erk and the RalGEF/Ral cascades are separate pathways, for instance, RasV12G37, RalGDS or Rlf-CAAX do not activate Erk (Wolthuis et al., 1997; White et al., 1996; Okazaki et al., 1997) and induction of gene expression by Rlf-CAAX occurs in an Erk-independent manner (Wolthuis et al., 1997) . The role of Erk in Rlf-CAAXinduced PrE dierentiation was investigated by either transfection of an interfering mutant of MEK, MEK-A222 (PageÁ s et al., 1994) , or by incubation with the MEK inhibitor PD98059 (Dudley et al., 1995) . Both MEK-A222 as well as PD98059 did not induce dierentiation by itself, nor did they inhibit RAinduced dierentiation. However, PD98059 completely inhibited RasV12-induced dierentiation (Figure 3a) . Transfection with MEK-A222 did not completely abolish RasV12-induced dierentiation, probably due to the inability of MEK-A222 to completely inhibit RasV12-induced Erk activation (not shown). Surprisingly, inhibition of Erk activation by either PD98059 or MEK-A222 completely abolished dierentiation induced by both Rlf-CAAX (Figure 3a) as well as RasV12G37 (not shown). This indicates that Erk is involved in RalGEF-mediated PrE dierentiation. However, Rlf-CAAX did not activate Erk ( Figure  3b) . Furthermore, Raf-CAAX at a concentration that induces comparable dierentiation as Rlf-CAAX (Figure 3c ), strongly activates Erk. Together with our observation that prolonged incubation with PD98059 reduced the basal level of Erk activity to approximately 40% of the control (Figure 3b ), this suggests that Rlf The identity of the factor(s) inducing PrE differentiation in the early mouse embryo is still unknown. RA is a strong inducer of F9 EC cells in vitro and induces activation of Ras (Verheijen et al., 1999) and Ral (not shown) in these cells. However, inhibition of Erk or RalGEF did not interfere with RA-induced PrE dierentiation nor did transfection with dominant negative Ras, RasAsn17 (data not shown). This suggests that RA can induce PrE dierentiation via Ras-independent pathways. Our observation that both the Ras/Erk pathway as well as the Ras/RalGEF pathway have the capacity to induce PrE differentiation in vitro, suggests that these signalling cascades play a major role in PrE dierentiation in vivo. Interestingly, Cheng et al. (1998) recently showed by introducing a null mutation into the mouse Grb2 gene, that Grb2-Ras signalling is required for endoderm dierentiation in vivo. Based on our results, we conclude that Ras induces endoderm dierentiation (at least in vitro) via an interplay of two pathways: a RalGEF mediated pathway which requires basal MEK or Erk activity to induce dierentiation, and the Raf1/Erk cascade which requires RalGEF activity for optimal induction of dierentiation (see Figure 4) . The downstream components involved in RalGEF-induced PrE differentiation are unclear. A possible target might be c-jun, since ectopic expression of c-jun in F9 EC cells is sucient for dierentiation to PrE and RalGEFs might in principle be able to regulate JNK activity via the putative Ral eector RalBP . LeppaÈ et al. (1998) , recently reported that induction of c-jun by the Erk pathway is required for JNK-induced neuronal dierentiation of PC12 cells. We observed that MEK or Erk activity is required for Rlf-induced PrE dierentiation of F9 EC cells. Interestingly, dierentiation induced by ectopic expression of c-jun could not be inhibited by PD98059 (data not shown). Whether there is a role for Erk-induced c-jun expression in RalGEF-mediated PrE dierentiation or whether, presently unknown, MEK substrates other than Erk are involved in this dierentiation process remains to be determined.
We observed that Raf1-induced dierentiation could be partly inhibited by RalN28. Assuming that RalN28 completely abolishes RalGEF activity this indicates that RalGEFs are at least contributing to differentia- tion by Raf1. If RalN28 does not completely inhibit RalGEF activity, dierentiation by Raf1 may be fully dependent on RalGEF activity, so that in the presence of RalN28 Raf1 utilizes residual RalGEF activity to trigger dierentiation. The requirement of RalGEFs in the action of Raf1 is also observed in Raf1-induced transformation of NIH3T3 ®broblasts, which was reported to be inhibited by RalN28 . The inhibition of Raf1-induced dierentiation and transformation by RalN28 might be explained by the requirement of basal RalGEF activity levels for optimal Raf1/Erk-induced dierentiation and transformation. It is also possible that RalN28 inhibits RalGEF activity induced by a Raf1-mediated autocrine loop. This is not unprecedented, since Raf1 mediates autocrine activation of JNKs in NIH3T3 cells (McCarthy et al., 1997) . However, transfection of F9 EC cells with constitutively active mutants of Ras, Raf1 or Rlf does not dierentiate the surrounding cells , treated with 50 mM PD98059 for 2 days, or cotransfected with Rlf-CAAX (0.6 mg) or Raf-CAAX (0.06 mg). The activity of HA-Erk was assayed using MBP as a substrate, as previously described (Verheijen and De®ze, 1995) (e.g. Figure 1a ), suggesting that putative secreted factors are not sucient to trigger dierentiation on their own.
Materials and methods

Materials
All-trans RA was purchased from Sigma; PD98059 from Calbiochem, and [g-32 P]ATP from Amersham (`s Hertogenbosch, The Netherlands). Monoclonal antibodies against SSEA-1 were a gift from D Solter (Wistar Institute, Philadelphia, PA, USA), monoclonal antibodies against TROMA-1 were a gift from R Kemler (Max-Planck-Institute for Immunobiology, Freiburg, Germany). The RasV12 and respective eector domain mutants were kindly provided by J Downward (Rodriguez-Viciana et al., 1997). Raf-CAAX was a gift from C Marshall (Leevers et al., 1994) , MEK-A222 was a gift from J PouysseÂ gur (PageÁ s et al., 1994) . The expression plasmids PMT2-HA-Rlf-CAAX, PMT2-HA-Rlf-DCAT-CAAX, PMT2-HA-RalN28 and PMT2-HA-RalV23 (Wolthuis et al., 1997) , as well as pSV2LacZ and pSG5-HAp42MAP (Verheijen et al., 1999) , have been described elsewhere.
Cell culture, induction of dierentiation and transfection F9 EC cells were obtained from the ATCC and cultured as described (Verheijen et al., 1999) . Transfections were performed usinig lipofectamin (Verheijen et al., 1999) with 0.3 mg pSV2-lacZ and 0.3 mg of indicated constructs, unless noted otherwise.
Activation of Erk
For determination of Erk activity epitope-tagged p42 HA-MAP kinase was immunoprecipitated with protein ASepharose beads coupled to monoclonal antibody 12CA5 (Verheijen and De®ze, 1995) . After the kinase reaction with MBP as a substrate, the reaction mix was subjected to SDSpolyacrylamide gel electrophoresis. Phosphorylation of MBP was measured using a PhosphorImager and ImageQuant software (Molecular Dynamics).
b-galactosidase staining and immuno¯uorescence
Cells were washed twice with PBS, ®xed with 2% paraformaldehyde, incubated with an X-Gal staining solution (PBS with 0.8 mg/ml X-Gal (Gibco ± BRL), 1 mg/ ml K 3 FE(CN) 6 , 1.3 mg/ml K 4 FE(CN) 6 ), and subsequently incubated with 20 mM NH 4 Cl for 30 min. Subsequent antibodies incubations for detection of SSEA-1 and Troma-1 were performed as described previously (Verheijen et al., 1999) .
